KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Common Equity (2016 - 2025)

Historic Common Equity for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • National Health Investors' Common Equity rose 2026.52% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2026.52%. This contributed to the annual value of $1.4 billion for FY2024, which is 877.86% up from last year.
  • As of Q3 2025, National Health Investors' Common Equity stood at $1.5 billion, which was up 2026.52% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Common Equity ranged from a high of $1.6 billion in Q1 2021 and a low of $1.2 billion during Q3 2024
  • For the 5-year period, National Health Investors' Common Equity averaged around $1.4 billion, with its median value being $1.4 billion (2024).
  • Its Common Equity has fluctuated over the past 5 years, first tumbled by 1561.67% in 2022, then surged by 2026.52% in 2025.
  • Over the past 5 years, National Health Investors' Common Equity (Quarter) stood at $1.5 billion in 2021, then fell by 15.62% to $1.3 billion in 2022, then fell by 1.23% to $1.3 billion in 2023, then grew by 8.78% to $1.4 billion in 2024, then grew by 8.29% to $1.5 billion in 2025.
  • Its Common Equity stands at $1.5 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.4 billion for Q1 2025.